Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Baxter
UBS
Deloitte
Federal Trade Commission
QuintilesIMS
Express Scripts
McKesson
US Army
Chubb

Generated: January 21, 2018

DrugPatentWatch Database Preview

MEXITIL Drug Profile

« Back to Dashboard

Which patents cover Mexitil, and what generic alternatives are available?

Mexitil is a drug marketed by Boehringer Ingelheim and is included in one NDA.

The generic ingredient in MEXITIL is mexiletine hydrochloride. There are five drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the mexiletine hydrochloride profile page.
Drug patent expirations by year for MEXITIL
Medical Subject Heading (MeSH) Categories for MEXITIL

US Patents and Regulatory Information for MEXITIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer Ingelheim MEXITIL mexiletine hydrochloride CAPSULE;ORAL 018873-002 Dec 30, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Boehringer Ingelheim MEXITIL mexiletine hydrochloride CAPSULE;ORAL 018873-003 Dec 30, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Boehringer Ingelheim MEXITIL mexiletine hydrochloride CAPSULE;ORAL 018873-004 Dec 30, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for MEXITIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim MEXITIL mexiletine hydrochloride CAPSULE;ORAL 018873-004 Dec 30, 1985 ➤ Subscribe ➤ Subscribe
Boehringer Ingelheim MEXITIL mexiletine hydrochloride CAPSULE;ORAL 018873-002 Dec 30, 1985 ➤ Subscribe ➤ Subscribe
Boehringer Ingelheim MEXITIL mexiletine hydrochloride CAPSULE;ORAL 018873-002 Dec 30, 1985 ➤ Subscribe ➤ Subscribe
Boehringer Ingelheim MEXITIL mexiletine hydrochloride CAPSULE;ORAL 018873-004 Dec 30, 1985 ➤ Subscribe ➤ Subscribe
Boehringer Ingelheim MEXITIL mexiletine hydrochloride CAPSULE;ORAL 018873-003 Dec 30, 1985 ➤ Subscribe ➤ Subscribe
Boehringer Ingelheim MEXITIL mexiletine hydrochloride CAPSULE;ORAL 018873-003 Dec 30, 1985 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Fuji
Mallinckrodt
Teva
Medtronic
Harvard Business School
Dow
Accenture
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot